CIK 0001837607
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853940478
- Phone
- +1 949-354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- Open-market buys, last 90 days
- $57,054
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$57,054. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Forth Marc Director | Grant or award | +222,684 | 973,231 | ||
| 2025-05-21 | Forth Marc Director | Grant or award · Restricted Stock Units | +370,370 | 370,370 | ||
| 2024-08-31 | Forth Marc CHIEF EXECTUIVE OFFICER | Grant or award | +470,692 | 750,547 | ||
| 2024-08-31 | Forth Marc CHIEF EXECTUIVE OFFICER | Grant or award · Stock Option | +1,256,062 | 1,256,062 | ||
| 2024-03-19 | Forth Marc CHIEF EXECTUIVE OFFICER | Grant or award · Stock Option | +212,466 | 212,466 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Stock Option | +970,588 | 970,588 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Stock Option | +324,021 | 324,021 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Stock Option | +291,332 | 291,332 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Stock Option | +381,480 | 381,480 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Stock Option | +194,118 | 194,118 | ||
| 2023-07-21 | Forth Marc Chief Executive Officer | Grant or award · Restricted Stock Units | +279,855 | 279,855 |
Page 1 of 1 · 11 trades